Search research articles
Contact Us
Filters
Showing results (1-10 of 212) with videos related to
Page
of 22
Sort By:
Arthritis and Rheumatism
|
September 6, 2005
Targeting the interleukin-15 system in rheumatoid arthritis
Thomas A Waldmann
Arthritis Research & Therapy
|
July 1, 2004
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
Thomas A Waldmann
Journal of Clinical Immunology
|
January 12, 2007
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey
Thomas A Waldmann
Cancer Immunology Research
|
March 5, 2015
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
Thomas A Waldmann
Cold Spring Harbor Perspectives in Biology
|
November 5, 2017
Cytokines in Cancer Immunotherapy
Thomas A Waldmann
Nature Reviews. Immunology
|
July 27, 2006
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A Waldmann
Annual Review of Medicine
|
January 18, 2006
Effective cancer therapy through immunomodulation
Thomas A Waldmann
Trends in Molecular Medicine
|
December 9, 2003
IL-15 in the life and death of lymphocytes: immunotherapeutic implications
Thomas A Waldmann
Annual Review of Immunology
|
October 3, 2002
The meandering 45-year odyssey of a clinical immunologist
Thomas A Waldmann
Expert Review of Clinical Immunology
|
November 1, 2014
Interleukin-15 in the treatment of cancer
Thomas A Waldmann
Page
of 22
Search research articles
Search
Showing results (1-10 of 212) with videos related to
Sort By:
Page
of 22
Arthritis and Rheumatism
|
September 6, 2005
Targeting the interleukin-15 system in rheumatoid arthritis
Thomas A Waldmann
Arthritis Research & Therapy
|
July 1, 2004
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
Thomas A Waldmann
Journal of Clinical Immunology
|
January 12, 2007
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey
Thomas A Waldmann
Cancer Immunology Research
|
March 5, 2015
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
Thomas A Waldmann
Cold Spring Harbor Perspectives in Biology
|
November 5, 2017
Cytokines in Cancer Immunotherapy
Thomas A Waldmann
Nature Reviews. Immunology
|
July 27, 2006
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A Waldmann
Annual Review of Medicine
|
January 18, 2006
Effective cancer therapy through immunomodulation
Thomas A Waldmann
Trends in Molecular Medicine
|
December 9, 2003
IL-15 in the life and death of lymphocytes: immunotherapeutic implications
Thomas A Waldmann
Annual Review of Immunology
|
October 3, 2002
The meandering 45-year odyssey of a clinical immunologist
Thomas A Waldmann
Expert Review of Clinical Immunology
|
November 1, 2014
Interleukin-15 in the treatment of cancer
Thomas A Waldmann
Page
of 22